Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Adept Biopharma logo — Creating groundbreaking immuno-therapeutics, leveraging worl...

Adept Biopharma

Creating groundbreaking immuno-therapeutics, leveraging world-class antibody discovery, and pioneering unique platforms for cancer treatment

Founded 2021 Angel Biotechnology, Health Care

General Information

Company Name Adept Biopharma
Founded Year 2021
Industries Biotechnology, Health Care
Funding Stage Angel
Social

Get notified when Adept Biopharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Adept Biopharma

Adept Biopharma is a promising startup dedicated to developing advanced immuno-therapeutics to assist cancer patients. The company's **groundbreaking immuno-therapeutics** aim to revolutionize cancer treatment. Adept Biopharma boasts expertise in **world-class antibody discovery** and offers a proprietary NKCE bispecific antibody platform, as well as an ABCC antibody/chemo/cytokine receptor trispecific antibody system. Additionally, the company has the capability to secure fully human antibodies through external **partnerships**. With its founding in **2021** and focus on **Biotechnology** and **Health Care**, Adept Biopharma has already secured an **Angel Round investment** on **01 January 2021** from **BIOCHING CAPITAL**. This startup shows great potential and is positioned to make a significant impact in the field of cancer treatment.

Taxonomy: immunotherapy, cancer treatment, antibody discovery, biopharmaceuticals, NKCE bispecific antibody, ABCC antibody, chemo/cytokine trispecific antibody, human antibodies, oncology, innovation, therapeutics, cancer research, pharmaceutical development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round •••••• 1
Investor
01 Jan 2021

Adept Biopharma Alternatives & Competitors

Adept Biopharma vs
Bright Biologics
Bright Biologics United States

Developing bispecific antibody drug to improve cancer treatment.

6 employees
Biotechnology, Health Care
Adept Biopharma vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post Ipo Equity
11 employees
Biopharma, Biotechnology
Adept Biopharma vs
Abalone Bio
Abalone Bio United States

Unleashing therapeutic biology.

23 employees

FAQ About Adept Biopharma

Creating groundbreaking immuno-therapeutics, leveraging world-class antibody discovery, and pioneering unique platforms for cancer treatment
Adept Biopharma was founded in 2021.
Adept Biopharma operates in the following industries: Biotechnology, Health Care.
Adept Biopharma has completed 1 funding round. The latest funding stage is Angel.
Top alternatives and competitors to Adept Biopharma include Bright Biologics, Apexigen, Abalone Bio, Eureka Therapeutics, Inc, Medarex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Adept Biopharma and Bright Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Adept Biopharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy